Shanghai Haimikang Intelligent Medical Technology
Brain-computer interface and exoskeleton rehabilitation solutions.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | CNY10.0m | Seed | |
| Total Funding | 000k | ||
Shanghai Haimikang Intelligent Medical Technology, also known as Ai Care, is a medical technology company founded in 2020 and headquartered in Shanghai, China. The firm specializes in developing solutions for patients with motor dysfunction, particularly in the hands, resulting from conditions like stroke or nerve damage.
The company's core offering is a lightweight, flexible exoskeleton that utilizes a brain-computer interface. This “brain-hand interaction” system translates a user's residual muscle signals from the forearm into natural control of the exoskeleton, assisting with movements like gripping and extending fingers. This technology is based on the principle of brain plasticity, aiming to facilitate patient rehabilitation. Ai Care integrates artificial intelligence, advanced sensors, and nanofabrication technologies into its therapeutic devices.
The company follows a research-driven model, collaborating with scientific teams from universities and clinical teams from major hospitals to ensure its products are grounded in both academic research and practical clinical application. In April 2024, Ai Care secured $1.38 million in an Early Stage Venture Capital funding round from New Access Capital.
Keywords: Brain-computer interface, exoskeleton, medical rehabilitation, therapeutic devices, motor dysfunction, brain plasticity, neurorehabilitation, artificial intelligence, medical technology, sensor technology, nanofabrication, brain-hand interaction, stroke rehabilitation, nerve damage treatment, wearable robotics